|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/23 | |
| A61K 31/225 | |||
| A61P 3/00 | |||
| A61P 3/02 | |||
| A61P 25/08 |
| (11) | Patento numeris | 2931269 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13862044.8 |
| Europos patento paraiškos padavimo data | 2013-12-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/075146 |
| Data | 2013-12-13 |
| (87) | Numeris | WO 2014/093901 |
| Data | 2014-06-19 |
| (30) | Numeris | Data | Šalis |
| 201261737013 P | 2012-12-13 | US | |
| 201361779942 P | 2013-03-13 | US |
| (72) |
SCHIFFMANN, Raphael, US
MOCHEL, Fanny, FR
|
| (73) |
Baylor Research Institute at Dallas,
2001 Bryan Street, Suite 2200, Dallas, TX 75201,
US
National Institute of Health and Medical Research, 101 rue de Tolbiac, 75654 Paris, FR |
| (54) | TRIHEPTANOIN FOR THE TREATMENT OF GLUCOSE TRANSPORTER 1 DEFICIENCY |
| TRIHEPTANOIN FOR THE TREATMENT OF GLUCOSE TRANSPORTER 1 DEFICIENCY |